Reasons Pharmacokinetics/Pharmacodynamics data are not being revealed is unknown to me.
I won’t speculate on this at all. It has nothing to do with whatever expertise I might contribute (reasonable, but not complete understanding of cellular chemistry and physiology). I will presume that Anavex is retaining the info for some presently inscrutable negotiations purpose, for some future corporate benefit.
I don’t doubt the data exist, nor that they are important. Why they are being retained is in the realm of financial negotiations, etc. Far beyond my ken. I try to stick only to the science of Anavex; nothing regarding share prices, etc.
But thank you for asking.